All News about Lexaria Bioscience Corp. - Common Stock![]() ![]()
Lexaria Bioscience (NASDAQ: LEXX) Comments on Study Examining Cannabinoids and SARS-CoV-2
January 19, 2022
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Comments Regarding Study Examining Cannabinoids and SARS-CoV-2
January 18, 2022
Via CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
![]() ![]()
Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2
January 18, 2022
Via AccessWire
![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|